84467-54-9 (1-[1-(4-氯苯基)环丁基]-3-甲基丁胺,Didesmethyl Sibutramine)

CAS号:
84467-54-9
中文名称:
1-[1-(4-氯苯基)环丁基]-3-甲基丁胺
英文名称:
Didesmethyl Sibutramine
分子式:
C15H22ClN
分子量:
251.79488325119

1-[1-(4-氯苯基)环丁基]-3-甲基丁胺(84467-54-9)名称与标识符

名称

中文别名:
1-(1-(4-氯苯基))-alpha-(2-甲基丙基)环丁烷 甲胺;1-(1-四氯苯基)-3-甲基-1-丁胺;1-[1-(4-氯苯基)环丁基]-3-甲基丁胺;
英文别名:
1-(1-(4-Chlorophenyl)cyclobutyl)-3-methylbutan-1-amine;Didesmethyl Sibutramine;1-[1-(4-Chlorophenyl)]-Alpha-(2-Methylpropyl) Cyclobutane Methanamine;1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine;Cyclobutanemethanamine,1-(4-chlorophenyl)-a-(2-methylpropyl)-;Didemethylsibutramine;N-Didemethylsibutramine;N-Didesmethylsibutramine;1-(4-Chlorophenyl)-α-(2-methylpropyl)cyclobutanemethanamine (ACI);(±)-Didesmethylsibutramine;1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutylamine;Cyclobutanemethanamine, 1-(4-chlorophenyl)-a-(2-methylpropyl)-;SCHEMBL2378931;CYCLOBUTANEMETHANAMINE, 1-(4-CHLOROPHENYL)-.ALPHA.-(2-METHYLPROPYL)-;SY225628;(1-(4-Chlorophenyl)cyclobutyl)-3-methylbutylamine;987R943R3P;NSC_134771;1-(1-(4-CHLOROPHENYL)CYCLOBUTYL)-3-METHYLBUTYLAMINE;AC6907;UNII-987R943R3P;NS00007524;BDBM84743;MFCD06658940;1-[1-(4-Chloropyenyl)cyclobutyl]-3-methylbutylamine;(-)-N,N-Didesmethylsibutramine;CS-0456114;Q27272099;1-[1-(4-Chloroprenyl)cyclobutyl]-3-Methylbutylamine;N-DIDESMETHYLSIBUTRAMINE [WHO-DD];AS-79118;84467-54-9;N-BIS-DESMETHYL-SIBUTRAMINE;1-(1-(4-CHLOROPHENYL)-2,2,3,3,4,4-HEXADEUTERIOCYCLOBUTYL)-3-METHYLBUTAN-1-AMINE;SCHEMBL682189;CHEMBL1625728;BRD-A68304895-003-02-2;AKOS015962045;DTXSID801004734;didesmethylsibutramine;(+/-)-Didesmethylsibutramine;Racemic 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine;1-[1-(4-Chlorophenyl)cyclobutyl]-3-methyl-1-butylamine;WQSACWZKKZPCHN-UHFFFAOYSA-N;CAS_134771;

标识符

MDL:
MFCD06658940
InChIKey:
WQSACWZKKZPCHN-UHFFFAOYSA-N
Inchi:
1S/C15H22ClN/c1-11(2)10-14(17)15(8-3-9-15)12-4-6-13(16)7-5-12/h4-7,11,14H,3,8-10,17H2,1-2H3
SMILES:
ClC1C=CC(C2(CCC2)C(CC(C)C)N)=CC=1

1-[1-(4-氯苯基)环丁基]-3-甲基丁胺(84467-54-9)物化性质

实验特性

  • LogP : 4.83540
  • PSA : 26.02000

计算特性

  • 精确分子量 : 251.14400
  • 氢键供体数量 : 1
  • 氢键受体数量 : 1
  • 可旋转化学键数量 : 4
  • 同位素质量 : 251.1440774g/mol
  • 重原子数量 : 17
  • 复杂度 : 239
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 1
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 4.5
  • 拓扑分子极性表面积 : 26Ų

1-[1-(4-氯苯基)环丁基]-3-甲基丁胺(84467-54-9)推荐厂家 更多厂家(16)

公司名称手机号/电话联系人QQ微信询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
赫澎(上海)生物科技有限公司 13122891558
186-16545970
张硕 3418426269
询单
金锦乐(湖南)化学有限公司 金锦乐 1226360695
询单
深圳市瑞吉特生物科技有限公司 15813841136
0755-89459231
钦先生 1029374309
询单
上海甄准生物科技有限公司 19301255008
021-68920155
徐经理19301255008 3004957527
询单
上海颖心实验室设备有限公司 17002132182
021-59178156
江玮倩 3146474380
询单
上海一基实业有限公司 13311756052
021-60526763 13311756052 13311756131
胡经理 2355265332
询单
上海一基实业有限公司 13311756131
021-60548336 QQ:2355265332 QQ:2851717387
胡经理 2355265332
询单
江苏艾康生物医药研发有限公司 18795912720
025-66061636
杨情情 3004779232
询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单

1-[1-(4-氯苯基)环丁基]-3-甲基丁胺(84467-54-9)合成路线

合成路线:1 步
反应条件:
参考文献:
Improvement on synthesis of sibutramine
Shen, Jing; et al, Zhongguo Yaowu Huaxue Zazhi, 2000, 10(2), 129-130
合成路线:1 步
反应条件:
参考文献:
A Study and Identification of Potential By-Products of Sibutramine
Reddy, G. Om; et al, Organic Process Research & Development, 1999, 3(6), 488-492
合成路线:1 步
反应条件:
参考文献:
Synthesis of sibutramine hydrochloride
Li, Jiaming; et al, Huaxi Yaoxue Zazhi, 2001, 16(2), 114-115
合成路线:1 步
反应条件:
参考文献:
Syntheses, characterizations and crystal structures of the Schiff bases derived from 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine
Pen, Zhenshan; et al, Huaxue Tongbao, 2009, 72(9), 820-827
合成路线:1 步
反应条件:
参考文献:
Novel diacid accelerated borane reducing agent for imines
Lu, Zhi-Hui; et al, Tetrahedron Letters, 2002, 43(47), 8617-8620
合成路线:2 步
反应条件:
参考文献:
Syntheses, characterizations and crystal structures of the Schiff bases derived from 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine
Pen, Zhenshan; et al, Huaxue Tongbao, 2009, 72(9), 820-827
合成路线:2 步
反应条件:
参考文献:
A Study and Identification of Potential By-Products of Sibutramine
Reddy, G. Om; et al, Organic Process Research & Development, 1999, 3(6), 488-492
合成路线:3 步
反应条件:
参考文献:
Synthesis of sibutramine hydrochloride
Shen, Jingshan; et al, Zhongguo Yiyao Gongye Zazhi, 2001, 32(8), 337-339

1-[1-(4-氯苯基)环丁基]-3-甲基丁胺(84467-54-9)相关文献

1-[1-(4-氯苯基)环丁基]-3-甲基丁胺(84467-54-9) MSDS

基础信息

Name:1-[1-(4-Chlorophenyl)Cyclobutyl]-3-Methylisobutylamine Citrate Material Safety Data Sheet
Synonym:None Known.
CAS:84467-54-9
Section 1 - Chemical Product MSDS Name: 1-[1-(4-Chlorophenyl)Cyclobutyl]-3-Methylisobutylamine Citrate Material Safety Data Sheet
Synonym: None Known.
SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS#Chemical NamecontentEINECS#
84467-54-91-[1-(4-Chlorophenyl)Cyclobutyl]-3-Metca. 100unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
SECTION 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW The toxicological properties of this material have not been fully investigated. Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.
SECTION 4 - FIRST AID MEASURES
Eyes:
Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
SECTION 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
SECTION 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation.
SECTION 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 84467-54-9: Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Crystals
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 173 - 174 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C21H30ClNO7
Molecular Weight: 443.92
SECTION 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
SECTION 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 84467-54-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-[1-(4-Chlorophenyl)Cyclobutyl]-3-Methylisobutylamine Citrate - Not listed by ACGIH, IARC, or NTP.
SECTION 12 - ECOLOGICAL INFORMATION
SECTION 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations.
SECTION 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material.
SECTION 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases: S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 84467-54-9: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 84467-54-9 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 84467-54-9 is not listed on the TSCA inventory. It is for research and development use only.
SECTION 16 - ADDITIONAL INFORMATION
MSDS Creation Date: 1/16/2002 Revision #2 Date: 10/05/2004 The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

SECTION 16 - ADDITIONAL INFORMATION
N/A